drugset / Trial / NCT06423729

Effect of Nicorandil in Type 2 Diabetic Obese Patients

NCT06423729

Phase 2/3 Unknown 46 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.

Timeline

Start
2024-06-01
Primary completion
2024-12
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicorandil Other / unclassified 10 mg Oral